Solving key challenges in cellular engineering
Our platform technologies offer unique and differentiated functionality to support a range of different cellular engineering applications, including biomanufacturing, disease model generation, and programmed cell differentiation.
We are always keen to speak to potential collaborators and partners on existing and novel applications – please get in touch!
Laverock's gene silencing platform is ideally suited to complex engineering of mammalian biomanufacturing systems, including CHO and HEK systems for antibody and viral vector production. Through our ability to stably and precisely control gene expression we offer the potential for metabolic engineering either for optimised bioproduction performance or improved product quality attributes, targeting single or multiplex genes/pathways in a single gene editing step.
Our programmable and tunable gene silencing approach can alter lineage specification through control of transcription factor expression at multiple stages, driving differentiation efficiency and ensuring enrichment of the functional cell product.
Generating relevant In-vitro disease models representing physiological gene expression is a key industry challenge, limiting drug screening and development. Our technology allows us to generate stable, tunable and allele / mutation specific target knock-down, opening new options for improved models and unlocking new disease targets.
